HepaVue Dx (Private limited company)
HepaVue Dx is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0803.100.414. It was founded on 23-06-2023. Its registered office is in Waterloo. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 429 994 and a loss of € 351 134. Addrly gives it a financial health grade of C, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 2 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of HepaVue Dx
| 2025 | 2024 | |
|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -351 134-736 % | € -42 023 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 429 994 | € -22 023 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 3 710 704+466 % | € 655 488 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -299 924-625 % | € -41 383 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Waterloo.
| Company | Town |
|---|---|
| RECHERCHE ET SANTE | 1410 Waterloo |
| OTORINO | 1410 Waterloo |
| ONCODERMA | 1410 Waterloo |
| ADVANCED MEDICAL DIAGNOSTICS | 1410 Waterloo |
| W | 1410 Waterloo |
| ELEONOR | 1410 Waterloo |
| COMPETENCES ET EQUILIBRE | 1410 Waterloo |
| RHUMAT-OS | 1410 Waterloo |
Frequently asked questions
Is HepaVue Dx still active? Yes. The Crossroads Bank for Enterprises lists HepaVue Dx as active.
What is the VAT number of HepaVue Dx? The VAT number of HepaVue Dx is BE 0803.100.414.
When was HepaVue Dx founded? HepaVue Dx was founded on 23-06-2023.
What is the address of HepaVue Dx? The current registered office of HepaVue Dx is Drève Richelle 161M, 1410 Waterloo.
When did HepaVue Dx last file annual accounts? The latest annual accounts of HepaVue Dx were filed on 26-08-2026.
Does HepaVue Dx file its annual accounts on time? Yes. HepaVue Dx filed its annual accounts within the legal deadline for each of its last 2 financial years.
Is HepaVue Dx financially healthy? Addrly gives HepaVue Dx a financial health grade of C, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is HepaVue Dx profitable? The annual accounts of HepaVue Dx for 2025 show a loss of € 351 134.
What is the equity of HepaVue Dx? The equity of HepaVue Dx was € 429 994 at the close of the 2025 financial year.
Who are the directors of HepaVue Dx? The annual accounts of HepaVue Dx record 1 mandate. The name, role and dates are visible with a free account.
Can HepaVue Dx receive Peppol e-invoices? Yes. HepaVue Dx is registered on the Peppol network and can receive structured electronic invoices.
What does HepaVue Dx do? The main activity of HepaVue Dx is: Scientific research and development.